Literature DB >> 2899245

Candida and AIDS: evidence for protective antibody.

R Matthews1, J Burnie, D Smith, I Clark, J Midgley, M Conolly, B Gazzard.   

Abstract

Clinical observation and animal models of candidosis suggest that, although T lymphocytes are important in preventing superficial candidosis, defence against systemic candidosis depends upon humoral immunity. An antibody response to the immunodominant 47 kD antigen of Candida albicans is invariably associated with recovery. The presence of this antibody in patients with chronic mucocutaneous candidosis and the acquired immunodeficiency syndrome (AIDS) could account for the rarity of disseminated candidal infection in these conditions. Polyclonal B cell activation may be responsible for the frequency with which this antibody is produced in AIDS. Antibody to the 47 kD antigen could be useful in the treatment and prevention of systemic candidosis, though not in the superficial candidosis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899245     DOI: 10.1016/s0140-6736(88)92547-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  R Narayanan; W A Joyce; R A Greenfield
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 4.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

5.  Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.

Authors:  L Romani; S Mocci; C Bietta; L Lanfaloni; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 6.  A retrospective study of Nocardia infections associated with the acquired immune deficiency syndrome (AIDS)

Authors:  P F Long
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

7.  Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum.

Authors:  Aida Pitarch; César Nombela; Concha Gil
Journal:  Mol Cell Proteomics       Date:  2010-09-21       Impact factor: 5.911

8.  Structure and regulation of the HSP90 gene from the pathogenic fungus Candida albicans.

Authors:  R K Swoboda; G Bertram; S Budge; G W Gooday; N A Gow; A J Brown
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.

Authors:  R K Swoboda; G Bertram; H Hollander; D Greenspan; J S Greenspan; N A Gow; G W Gooday; A J Brown
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.